AIRLINK 88.00 Increased By ▲ 0.90 (1.03%)
BOP 4.88 Increased By ▲ 0.13 (2.74%)
CNERGY 3.84 Decreased By ▼ -0.07 (-1.79%)
DFML 40.35 Decreased By ▼ -0.05 (-0.12%)
DGKC 90.06 Decreased By ▼ -0.74 (-0.81%)
FCCL 22.85 Increased By ▲ 0.15 (0.66%)
FFBL 35.36 Increased By ▲ 0.92 (2.67%)
FFL 8.90 Decreased By ▼ -0.09 (-1%)
GGL 9.53 Decreased By ▼ -0.18 (-1.85%)
HASCOL 6.20 Increased By ▲ 0.15 (2.48%)
HBL 124.00 Increased By ▲ 0.02 (0.02%)
HUBC 163.24 Decreased By ▼ -1.26 (-0.77%)
HUMNL 10.25 Decreased By ▼ -0.26 (-2.47%)
KEL 4.56 Decreased By ▼ -0.12 (-2.56%)
KOSM 4.10 Decreased By ▼ -0.03 (-0.73%)
MLCF 37.84 Decreased By ▼ -0.35 (-0.92%)
OGDC 135.26 Decreased By ▼ -1.14 (-0.84%)
PAEL 24.60 Decreased By ▼ -0.16 (-0.65%)
PIBTL 6.11 Decreased By ▼ -0.29 (-4.53%)
PPL 117.15 Decreased By ▼ -0.36 (-0.31%)
PRL 23.18 Decreased By ▼ -0.04 (-0.17%)
PTC 12.01 Increased By ▲ 1.09 (9.98%)
SEARL 57.08 Decreased By ▼ -0.37 (-0.64%)
SNGP 64.00 Decreased By ▼ -0.20 (-0.31%)
SSGC 9.49 Decreased By ▼ -0.08 (-0.84%)
TELE 7.33 Increased By ▲ 0.03 (0.41%)
TPLP 8.80 Decreased By ▼ -0.09 (-1.01%)
TRG 61.25 Decreased By ▼ -0.97 (-1.56%)
UNITY 29.91 Increased By ▲ 0.52 (1.77%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 8,275 Decreased By -37.7 (-0.45%)
BR30 26,472 Decreased By -106.4 (-0.4%)
KSE100 78,445 Decreased By -83.3 (-0.11%)
KSE30 25,282 Decreased By -150.7 (-0.59%)
Business & Finance

India's Glenmark Pharma announces discovery of new monoclonal antibody

MUMBAI: Indian drugmaker Glenmark Pharmaceuticals said on Monday it has discovered a new molecule that can be used to
Published February 4, 2013

glenmark pharmaceuticals 40MUMBAI: Indian drugmaker Glenmark Pharmaceuticals said on Monday it has discovered a new molecule that can be used to treat diseases such as rheumatoid arthritis and inflammatory bowel disease.

 

The new molecule, named GBR 830, is an anti-OX40 monoclonal antibody, Glenmark said in a statement, adding that OX40 is responsible for some autoimmune diseases.

 

The company said it has initiated studies for an investigational new drug (IND) application to be filed with the US Food and Drug Administration.

Copyright Reuters, 2013

Comments

Comments are closed.